CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 41 enrolled
Drug / intervention
FSH (Follicle Stimulating Hormone)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01785095
NCT01785095Phase 3Completed
CompareCT.gov

Prospective, Open-label, Uncontrolled Clinical Trial Evaluating Multiple Controlled Ovarian Hyperstimulation Cycles in Oocyte Donor, to Assess the Immunogenicity of FSH-IBSA

IBSA Institut Biochimique SA·interventional·Posted Feb 7, 2013·Updated Feb 9, 2017

In Brief

A Phase 3 clinical trial evaluating FSH (Follicle Stimulating Hormone) for Oocyte Donation. Completed, enrolled 41 participants across 1 site.

Detailed Summary

The purpose of the study is to evaluate immunogenic potential of FSH-IBSA in healthy volunteers undergoing controlled ovarian hyperstimulation (COH) in an oocyte donation program.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOocyte Donation
CountriesSpain
Collaborators--

Timeline

Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 7, 2013
Enrollment StartMar 1, 2013
Primary CompletionJul 1, 2014
Study CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 13.4 years ago

Interventions

FSH (Follicle Stimulating Hormone)drug